DealJournal posts

Feed

Newspaper wrap-up: AT&T to pursue DirecTV?

MAJOR PAPERS:
OTHER PAPERS:
  • The U.S. Department of Veteran Affairs has decided to sharply limit the use of GlaxoSmithKline's (NYSE: GSK) once-popular drug for Type 2 diabetes, Avandia. The decision is likely to further reduce revenue from Avandia, whose sales have dropped in the U.S. by an estimated 60% in the last five months, reported the New York Times.
  • Goldman Sachs Group (NYSE: GS) said it would pay $172M for a majority stake in Indian metal castings maker Sigma Electricals and its affiliated companies, reported the Business Standard.
  • A molecular diagnostic test for HPV developed by Digene, which is now part of Qiagen (NASDAQ: QGEN), has been found to be almost 40% more accurate than traditional cytology in identifying women with advanced cervical disease, according to a report published today in The New England Journal of Medicine.

Symbol Lookup
IndexesChangePrice
DJIA+12.8510,624.69
NASDAQ-0.802,367.66
S&P 500-0.251,149.99

Last updated: March 15, 2010: 12:21 AM

Hot Stocks

General Electric

17.04+0.56(+3.40)

Alcoa

13.60-0.04(-0.29)

Apple Inc

226.60+1.10(+0.49)

Google Inc 'A'

579.54-1.60(-0.28)

Bank of America

16.85-0.27(-1.58)

Wal-Mart Stores

53.90-0.07(-0.13)

Exxon Mobil Corp

66.80-0.42(-0.62)

Ford

13.34+0.43(+3.33)

Citigroup

3.97-0.21(-5.02)

IBM

127.94+0.34(+0.27)

Yahoo

16.32-0.21(-1.27)

Starbucks

24.28+0.01(+0.04)

Microsoft

29.27+0.09(+0.31)

Home Depot

32.45+0.32(+1.00)

DailyFinance Headlines

WalletPop Headlines

AOL Business News

BioHealth Investor Headlines

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

CNNMoney Headlines

More CNNMoney.com

Financial Times Headlines

More Financial Times

CNBC Headlines

More CNBC.com

SmartMoney Headlines

More SmartMoney

Fox Business Headlines

More Fox Business

Engadget Headlines

More Engadget